Nolvadex is the brand name for tamoxifen a selective estrogen receptor modulator used in the treatment of hormone receptor positive breast cancer. It works by binding to estrogen receptors in breast tissue and blocking the action of estrogen which can stimulate tumor growth. By antagonizing estrogen signaling it reduces proliferation of cancer cells and can also affect other estrogen dependent tissues. The drug is absorbed orally and metabolized in the liver to active metabolites that exert anti estrogenic effects. These metabolites block estrogen mediated pathways leading to reduced tumor growth and improved clinical response. Its therapeutic purpose is to modulate estrogen driven processes and provide benefit in both early stage and advanced disease.

Nolvadex is the brand name for the selective estrogen receptor modulator tamoxifen citrate. It is classified as a non-steroidal anti-estrogenic agent that binds to estrogen receptors in target tissues. By occupying these receptors it prevents the binding of endogenous estrogens and thereby reduces estrogenic signaling in breast cells. In post-menopausal women with hormone-responsive breast cancer this blockade leads to slowed tumor growth and improved clinical outcomes. The same antagonistic effect on pituitary estrogen receptors stimulates the release of gonadotropins and can induce ovulation in infertile patients. Pharmacologically the drug is metabolized in the liver to active metabolites that exhibit a long plasma half-life, allowing once-daily administration. Its high affinity for the estrogen receptor and partial agonist activity enable it to act as an antagonist in breast tissue while acting as an agonist in bone and endometrium. This dual antagonism underlies its therapeutic use for both cancer treatment and ovulation induction.

Nausea may occur in some users. Hot flashes can cause sudden warmth and sweating. Weight changes such as mild gain or loss are reported. Vaginal discharge or irritation can happen occasionally. Fatigue may reduce energy levels during treatment. Mood swings including irritability or mild depression are possible. Rare but notable liver enzyme elevations may be detected in blood tests. Certain visual disturbances like blurred sight have been noted in a small number of cases.

Nolvadex is commonly prescribed for hormone receptor positive breast cancer. One frequent side effect is hot flashes, which involve sudden warmth and sweating. Some users also report mild nausea or gastrointestinal discomfort. Fatigue and headache are reported by a notable portion of patients. Occasional visual disturbances such as blurred vision may occur. Long term use can lead to changes in the uterine lining that require monitoring. Overall the medication is generally well tolerated with these relatively common reactions.